Induced sputum in cystic fibrosis: Within-week reproducibility of inflammatory markers

Clinical Biochemistry

Volumn 37, Issue 11, 2004, Pages 1031-1036

  Smountas, Argyrios A ^a   Lands, Larry C ^a   Mohammed, Shawn R ^a   Grey, Vijaylaxmi ^b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b Hamilton Hlth Sci Hamilton O   (New Zealand)

Author keywords

Cystic Fibrosis; Inflammation; Reproducibility; Sputum

Indexed keywords

BIOLOGICAL MARKER; DITHIOTHREITOL; INTERLEUKIN 8; LEUKOCYTE ELASTASE; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISPERSION; FEMALE; HUMAN; INFLAMMATION; MALE; NEBULIZER; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DETERMINATION; REPRODUCIBILITY; SPUTUM; SPUTUM ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION; MALE; REPRODUCIBILITY OF RESULTS; SPUTUM;

EID: 6344231963     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.07.008     Document Type: Article

References (36)

1. V.M. Keatings, P.D. Collins, D.M. Scott, and P.J. Barnes Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma Am. J. Respir. Crit. Care Med. 153 1996 530 534
2. I. Pin, P.G. Gibson, and R. Kolendowicz Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 47 1992 25 29
3. M.M. Pizzichini, T.A. Popov, and A. Efthimiadis Spontaneous and induced sputum to measure indices of airway inflammation in asthma Am. J. Respir. Crit. Care Med. 154 1996 866 869
4. R.M. Streiter, N.W. Lukacs, T.J. Standiford, and S.L. Kunkel Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung Thorax 48 1993 765 769
5. M. Baggiolini, A. Walz, and S.L. Kunkel Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils J. Clin. Invest. 84 1989 1045 1049
6. S. Suter, U.B. Schaad, and H. Tegner Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa J. Infect. Dis. 153 1986 902 909
7. P. Birrer, N.G. McElvaney, and A. Rudeberg Proteaseâ€" antiprotease imbalance in the lungs of children with cystic fibrosis Am. J. Respir. Crit. Care Med. 150 1994 207 213
8. R.L. Henry, P.G. Gibson, K. Carty, Y. Cai, and P.L. Francis Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis Pediatr. Pulmonol. 26 1998 97 100
9. P.S. Salva, N.A. Doyle, L. Graham, H. Eigen, and C.F. Doershuk TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients Pediatr. Pulmonol. 21 1996 11 19
10. T. Popov, R. Gottschalk, and R. Kolendowicz The evaluation of a cell dispersion method of sputum examination Clin. Exp. Allergy 24 1994 778 783
11. E. Pizzichini, M.M. Pizzichini, A. Efthimiadis, F.E. Hargreave, and J. Dolovich Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination Eur. Respir. J. 9 1996 1174 1180
12. A. Efthimiadis, M.M. Pizzichini, E. Pizzichini, J. Dolovich, and F.E. Hargreave Induced sputum cell and fluid phase indices of inflammation: comparison of treatment with dithiothreitol vs. phosphate-buffered saline Eur. Respir. J. 10 1997 1336 1340
13. Y. Cai, K. Carty, P. Gibson, and R. Henry Comparison of sputum processing techniques in cystic fibrosis Pediatr. Pulmonol. 22 1996 402 407
14. K.W. Tsang, P.L. Ho, and W.K. Lam Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis Am. J. Respir. Crit. Care Med. 158 1998 723 727
15. A. Bhowmik, T.A. Seemungal, R.J. Sapsford, and J.A. Wedzicha Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax 55 2000 114 120
16. J.V. Fahy, H.A. Boushey, and S.C. Lazarus Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study Am. J. Respir. Crit. Care Med. 163 2001 1470 1475
17. E. Pizzichini, M.M. Pizzichini, and A. Efthimiadis Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements Am. J. Respir. Crit. Care Med. 154 1996 308 317
18. J.C. in 't Veen, H.W. deGouw, and H.H. Smits Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma Eur. Respir. J. 9 1996 2441 2447
19. N.M. Wilson, P. Bridge, A. Spanevello, and M. Silverman Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity Thorax 55 2000 768 774
20. A. Spanevello, G.B. Migliori, and A. Sharara Induced sputum to assess airway inflammation: a study of reproducibility Clin. Exp. Allergy 27 1997 1138 1144
21. C.E. Brightling, W. Monterio, and R.H. Green Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability Respir. Med. 95 2001 999 1002
22. M. Purokivi, J. Randell, M.R. Hirvonen, and H. Tukiainen Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum Eur. Respir. J. 16 2000 242 246
23. C.L. Ordoñez, M. Stulbarg, H. Grundland, J.T. Liu, and H.A. Boushey Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study Pediatr. Pulmonol. 32 2001 29 37
24. H. Liu, S.C. Lazarus, G.H. Caughey, and J.V. Fahy Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro Am. J. Physiol. 276 1999 L28 L34
25. A. Bhowmik, T.A. Seemungal, R.J. Sapsford, J.L. Devalia, and J.A. Wedzicha Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease Thorax 53 1998 953 956
26. A. Cantin, G. Bilodeau, and R. Begin Granulocyte elastase-mediated proteolysis of alpha 1-antitrypsin in cystic fibrosis bronchopulmonary secretions Pediatr. Pulmonol. 7 1989 12 17
27. S. Chinn Statistics in respiratory medicine. 2. Repeatability and method comparison Thorax 46 1991 454 456
28. S. Chinn Statistics in respiratory medicine. 1. Ranges, confidence intervals, and related quantities: what they are and when to use them Thorax 46 1991 391 393
29. G. Kronborg, M.B. Hansen, and M. Svenson Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs Pediatr. Pulmonol. 15 1993 292 297
30. J.M. Wolter, R.L. Rodwell, S.D. Bowler, and J.G. McCormack Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis Clin. Diagn. Lab. Immunol. 6 1999 260 265
31. L.S. Nixon, B. Yung, S.C. Bell, J.S. Elborn, and D.J. Shale Circulating immunoreactive interleukin-6 in cystic fibrosis Am. J. Respir. Crit. Care Med. 157 1998 1764 1769
32. K. Balough, M. McCubbin, and M. Weinberger The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis Pediatr. Pulmonol. 20 1995 63 70
33. J.S. Pober, M.A. Gimbrone Jr., and L.A. Lapierre Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon J. Immunol. 137 1986 1893 1896
34. O.J. Kwon, B.T. Au, and P.D. Collins Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells Immunology 81 1994 389 394
35. M.A. Cassatella, L. Meda, S. Bonora, M. Ceska, and G. Constantin Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide J. Exp. Med. 178 1993 2207 2211
36. S.D. Sagel, M.K. Sontag, J.S. Wagener, R.K. Kapsner, I. Osberg, and F.J. Accurso Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis J. Pediatr. 141 2002 811 817